VEEV Quote, Financials, Valuation and Earnings

Schrodinger has a net margin of 26.57% compared to Veeva Systems's net margin of -108.07%. Veeva Systems's return on equity of 13.54% beat Schrodinger's return on equity of -34.83%.

Veeva Systems has a consensus price target of $268.70, signalling upside risk potential of 19.88%. On the other hand Schrodinger has an analysts' consensus of $32.00 which suggests that it could grow by 64.61%. Given that Schrodinger has higher upside potential than Veeva Systems, analysts believe Schrodinger is more attractive than Veeva Systems.

Veeva Systems has a beta of 0.821, which suggesting that the stock is 17.902% less volatile than S&P 500. In comparison Schrodinger has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veeva Systems pays -- of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend.

Veeva Systems quarterly revenues are $699.2M, which are larger than Schrodinger quarterly revenues of $35.3M. Veeva Systems's net income of $185.8M is higher than Schrodinger's net income of -$38.1M. Notably, Veeva Systems's price-to-earnings ratio is 55.35x while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 13.89x versus 7.36x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

Simulations Plus has a net margin of 26.57% compared to Veeva Systems's net margin of 16.92%. Veeva Systems's return on equity of 13.54% beat Simulations Plus's return on equity of 5.55%.

Veeva Systems has a consensus price target of $268.70, signalling upside risk potential of 19.88%. On the other hand Simulations Plus has an analysts' consensus of -- which suggests that it could grow by 74.95%. Given that Simulations Plus has higher upside potential than Veeva Systems, analysts believe Simulations Plus is more attractive than Veeva Systems.

Veeva Systems has a beta of 0.821, which suggesting that the stock is 17.902% less volatile than S&P 500. In comparison Simulations Plus has a beta of 0.758, suggesting its less volatile than the S&P 500 by 24.231%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus offers a yield of 0.84% to investors and pays a quarterly dividend of $0.06 per share. Veeva Systems pays -- of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Veeva Systems quarterly revenues are $699.2M, which are larger than Simulations Plus quarterly revenues of $18.5M. Veeva Systems's net income of $185.8M is higher than Simulations Plus's net income of $3.1M. Notably, Veeva Systems's price-to-earnings ratio is 55.35x while Simulations Plus's PE ratio is 58.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 13.89x versus 8.29x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.

Nano Mobile Healthcare has a net margin of 26.57% compared to Veeva Systems's net margin of --. Veeva Systems's return on equity of 13.54% beat Nano Mobile Healthcare's return on equity of --.

Veeva Systems has a consensus price target of $268.70, signalling upside risk potential of 19.88%. On the other hand Nano Mobile Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Veeva Systems has higher upside potential than Nano Mobile Healthcare, analysts believe Veeva Systems is more attractive than Nano Mobile Healthcare.

Veeva Systems has a beta of 0.821, which suggesting that the stock is 17.902% less volatile than S&P 500. In comparison Nano Mobile Healthcare has a beta of -0.315, suggesting its less volatile than the S&P 500 by 131.476%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nano Mobile Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veeva Systems pays -- of its earnings as a dividend. Nano Mobile Healthcare pays out -- of its earnings as a dividend.

Veeva Systems quarterly revenues are $699.2M, which are larger than Nano Mobile Healthcare quarterly revenues of --. Veeva Systems's net income of $185.8M is higher than Nano Mobile Healthcare's net income of --. Notably, Veeva Systems's price-to-earnings ratio is 55.35x while Nano Mobile Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 13.89x versus -- for Nano Mobile Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Xsovt Brands has a net margin of 26.57% compared to Veeva Systems's net margin of --. Veeva Systems's return on equity of 13.54% beat Xsovt Brands's return on equity of --.

Veeva Systems has a consensus price target of $268.70, signalling upside risk potential of 19.88%. On the other hand Xsovt Brands has an analysts' consensus of -- which suggests that it could fall by --. Given that Veeva Systems has higher upside potential than Xsovt Brands, analysts believe Veeva Systems is more attractive than Xsovt Brands.

Veeva Systems has a beta of 0.821, which suggesting that the stock is 17.902% less volatile than S&P 500. In comparison Xsovt Brands has a beta of 5.536, suggesting its more volatile than the S&P 500 by 453.568%.

Veeva Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xsovt Brands offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Veeva Systems pays -- of its earnings as a dividend. Xsovt Brands pays out -- of its earnings as a dividend.

Veeva Systems quarterly revenues are $699.2M, which are larger than Xsovt Brands quarterly revenues of --. Veeva Systems's net income of $185.8M is higher than Xsovt Brands's net income of --. Notably, Veeva Systems's price-to-earnings ratio is 55.35x while Xsovt Brands's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Veeva Systems is 13.89x versus -- for Xsovt Brands. Usually stocks with elevated PS ratios are considered overvalued.